المؤلفون: Argolo ADS; Department of Sanitary and Environmental Engineering, Rio de Janeiro State University, Rio de Janeiro, Brazil. Electronic address: argolo.allan@posgraduacao.uerj.br., Gomes G; Department of Biology & CESAM, University of Aveiro, Aveiro, Portugal., Bila DM; Department of Sanitary and Environmental Engineering, Rio de Janeiro State University, Rio de Janeiro, Brazil.

المصدر: Chemosphere [Chemosphere] 2023 Jan; Vol. 310, pp. 136917. Date of Electronic Publication: 2022 Oct 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 0320657 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1298 (Electronic) Linking ISSN: 00456535 NLM ISO Abbreviation: Chemosphere Subsets: MEDLINE

مواضيع طبية MeSH: Water Pollutants, Chemical*/analysis , Endocrine Disruptors*/toxicity , Endocrine Disruptors*/analysis, Dissolved Organic Matter ; Estrogens/analysis ; Estradiol/analysis ; Estrone/analysis ; Estrogen Antagonists/analysis ; Environmental Monitoring/methods

المؤلفون: Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Bartlett Hall Extension 237, 55 Fruit St, Boston, MA, 02114, USA. bardia.aditya@mgh.harvard.edu., Mayer I; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; AstraZeneca, Gaithersburg, MD, USA., Winer E; Dana-Farber Cancer Institute, Boston, MA, USA.; Yale Cancer Center, New Haven, CT, USA., Linden HM; University of Washington, Seattle, WA, USA., Ma CX; Washington University School of Medicine, St. Louis, MO, USA., Parker BA; University of California San Diego Moores Cancer Center, San Diego, CA, USA., Bellet M; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, USA., Cheeti S; Genentech, Inc, South San Francisco, CA, USA., Gates M; Genentech, Inc, South San Francisco, CA, USA., Chang CW; Genentech, Inc, South San Francisco, CA, USA., Fredrickson J; Genentech, Inc, South San Francisco, CA, USA., Spoerke JM; Genentech, Inc, South San Francisco, CA, USA., Moore HM; Genentech, Inc, South San Francisco, CA, USA., Giltnane J; Genentech, Inc, South San Francisco, CA, USA., Friedman LS; Genentech, Inc, South San Francisco, CA, USA.; ORIC Pharmaceuticals, South San Francisco, CA, USA., Chow Maneval E; ORIC Pharmaceuticals, South San Francisco, CA, USA., Chan I; Genentech, Inc, South San Francisco, CA, USA., Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, Weill Cornell Medical College, New York, NY, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jan; Vol. 197 (2), pp. 319-331. Date of Electronic Publication: 2022 Nov 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology, Humans ; Female ; Receptors, Estrogen/genetics ; Receptor, ErbB-2/genetics ; Ligands ; Postmenopause ; Estrogen Antagonists/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Nishihara R; Ryo Nishihara, MD, Akihiko Shimomura, MD, PhD, and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan., Shimomura A; Ryo Nishihara, MD, Akihiko Shimomura, MD, PhD, and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan., Shimizu C; Ryo Nishihara, MD, Akihiko Shimomura, MD, PhD, and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Dec 20; Vol. 40 (36), pp. 4280-4281. Date of Electronic Publication: 2022 Sep 06.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Estrogen* , Breast Neoplasms*/drug therapy, Humans ; Female ; Cyclin-Dependent Kinase 4 ; Estrogen Antagonists ; Cyclin-Dependent Kinase 6 ; Estrogen Receptor alpha ; Protein Kinase Inhibitors/adverse effects

المؤلفون: Chanvijit S; Interdisciplinary Program in Pharmacology, Graduate School, Chulalongkorn University, Bangkok, 10330, Thailand., Phuagkhaopong S; Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathumwan, Bangkok, 10330, Thailand., Mahalapbutr P; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand., Klaewkla M; Future Health Innovation Technology Co., Ltd., Bangkok, 10170, Thailand., Chavasiri W; Center of Excellence in Natural Products Chemistry, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand., Wonganan P; Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathumwan, Bangkok, 10330, Thailand. Piyanuch.W@chula.ac.th.

المصدر: Scientific reports [Sci Rep] 2022 Nov 16; Vol. 12 (1), pp. 19668. Date of Electronic Publication: 2022 Nov 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/metabolism, Humans ; Ether ; Proto-Oncogene Proteins c-akt/metabolism ; Tumor Suppressor Protein p53 ; Molecular Docking Simulation ; Ethyl Ethers/therapeutic use ; Estrogen Antagonists/pharmacology

المؤلفون: Miller ES; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Sakowicz A; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Roy A; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Liu LY; Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York., Yee LM; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

المصدر: American journal of obstetrics & gynecology MFM [Am J Obstet Gynecol MFM] 2019 May; Vol. 1 (2), pp. 144-147. Date of Electronic Publication: 2019 Apr 28.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101746609 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-9333 (Electronic) Linking ISSN: 25899333 NLM ISO Abbreviation: Am J Obstet Gynecol MFM

مواضيع طبية MeSH: 17 alpha-Hydroxyprogesterone Caproate/*adverse effects , Estrogen Antagonists/*adverse effects , Postpartum Hemorrhage/*etiology , Premature Birth/*prevention & control , Progestins/*adverse effects, 17 alpha-Hydroxyprogesterone Caproate/administration & dosage ; 17 alpha-Hydroxyprogesterone Caproate/therapeutic use ; Adult ; Estrogen Antagonists/administration & dosage ; Estrogen Antagonists/therapeutic use ; Female ; Humans ; Hydroxyprogesterones/therapeutic use ; Infant, Newborn ; Postpartum Hemorrhage/epidemiology ; Pregnancy ; Premature Birth/epidemiology ; Progestins/administration & dosage ; Progestins/therapeutic use ; Retrospective Studies

المؤلفون: Sharma A, Toy W; Human Oncology and Pathogenesis Program , Memorial Sloan Kettering Cancer Center , New York , New York 10065 , United States., Guillen VS, Sharma N, Min J, Carlson KE, Mayne CG, Lin S, Sabio M, Greene G; The Ben May Department for Cancer Research , University of Chicago , Chicago , Illinois 60637 , United States., Katzenellenbogen BS, Chandarlapaty S; Human Oncology and Pathogenesis Program , Memorial Sloan Kettering Cancer Center , New York , New York 10065 , United States., Katzenellenbogen JA

المصدر: ACS chemical biology [ACS Chem Biol] 2018 Dec 21; Vol. 13 (12), pp. 3374-3384. Date of Electronic Publication: 2018 Nov 26.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol

مواضيع طبية MeSH: Estrogen Antagonists/*pharmacology , Estrogen Receptor Modulators/*pharmacology , Estrogen Receptor alpha/*antagonists & inhibitors , Phenols/*pharmacology, Binding Sites ; Cell Proliferation/drug effects ; Down-Regulation ; Estradiol/analogs & derivatives ; Estradiol/chemistry ; Estrogen Antagonists/chemical synthesis ; Estrogen Antagonists/chemistry ; Estrogen Receptor Modulators/chemical synthesis ; Estrogen Receptor Modulators/chemistry ; Estrogen Receptor alpha/genetics ; Humans ; Ligands ; MCF-7 Cells ; Molecular Docking Simulation ; Molecular Structure ; Mutation ; Phenols/chemical synthesis ; Phenols/chemistry

المؤلفون: Ye H; Department of Physical & Chemical Sciences, University of Canterbury, Christchurch, New Zealand., Dudley SZ; Department of Physical & Chemical Sciences, University of Canterbury, Christchurch, New Zealand., Shaw IC; Department of Physical & Chemical Sciences, University of Canterbury, Christchurch, New Zealand. Electronic address: ian.shaw@canterbury.ac.nz.

المصدر: Toxicology [Toxicology] 2018 Sep 01; Vol. 408, pp. 80-87. Date of Electronic Publication: 2018 Jul 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Ireland NLM ID: 0361055 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3185 (Electronic) Linking ISSN: 0300483X NLM ISO Abbreviation: Toxicology Subsets: MEDLINE

مواضيع طبية MeSH: Estrogen Antagonists/*pharmacology , Estrogen Receptor alpha/*drug effects , Estrogens/*pharmacology , Selective Estrogen Receptor Modulators/*pharmacology , Signal Transduction/*drug effects, Animals ; Binding Sites ; Estrogen Antagonists/chemistry ; Estrogen Antagonists/metabolism ; Estrogen Receptor alpha/chemistry ; Estrogen Receptor alpha/metabolism ; Estrogens/chemistry ; Estrogens/metabolism ; Gene Expression Regulation/drug effects ; Humans ; Ligands ; Models, Molecular ; Molecular Mimicry ; Protein Binding ; Protein Conformation ; Selective Estrogen Receptor Modulators/chemistry ; Selective Estrogen Receptor Modulators/metabolism ; Structure-Activity Relationship

المؤلفون: Chen YC; Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA., Yu J; Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA., Metcalfe C; Discovery Oncology, Genentech, Inc., South San Francisco, CA, USA., De Bruyn T; Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA., Gelzleichter T; Genentech Research and Early Development, Genentech, Inc., South San Francisco, CA, USA., Malhi V; Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA., Perez-Moreno PD; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Wang X; Discovery Chemistry, Genentech, Inc., South San Francisco, CA, USA.

المصدر: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2022 Jun; Vol. 31 (6), pp. 515-529. Date of Electronic Publication: 2021 Oct 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Receptors, Estrogen*/metabolism, Estrogen Antagonists/pharmacology ; Estrogen Antagonists/therapeutic use ; Female ; Fulvestrant/pharmacokinetics ; Fulvestrant/therapeutic use ; Humans ; Quality of Life ; Selective Estrogen Receptor Modulators/adverse effects

المؤلفون: Wester L; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Venneker S; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Hazenoot M; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Pont C; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Koedoot E; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Kockx CEM; Centre for Biomics, Erasmus MC Rotterdam, Netherlands., van IJcken WFJ; Centre for Biomics, Erasmus MC Rotterdam, Netherlands., Meerman JHN; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Zhang Y; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., van de Water B; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands. Electronic address: b.water@lacdr.leidenuniv.nl.

المصدر: Biochemical pharmacology [Biochem Pharmacol] 2022 Oct; Vol. 204, pp. 115233. Date of Electronic Publication: 2022 Aug 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2968 (Electronic) Linking ISSN: 00062952 NLM ISO Abbreviation: Biochem Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/metabolism , Estrogen Receptor Modulators*/pharmacology , Estrogen Receptor Modulators*/therapeutic use, Anaplastic Lymphoma Kinase ; Benzamides ; Cell Line, Tumor ; Diphenylamine/analogs & derivatives ; Drug Resistance, Neoplasm ; ErbB Receptors ; Estrogen Antagonists/pharmacology ; Estrogen Receptor alpha/metabolism ; Female ; Humans ; Insulin-Like Growth Factor I ; Mitogen-Activated Protein Kinase Kinases ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Receptor, IGF Type 1 ; Tamoxifen/pharmacology ; Tamoxifen/therapeutic use

المؤلفون: Bidard FC; Institut Curie, Paris and Saint Cloud, France.; Versailles Saint Quentin/Paris-Saclay University, Saint Cloud, France., Kaklamani VG; University of Texas Health Sciences Center, San Antonio, TX., Neven P; Universitaire Ziekenhuizen (UZ)-Leuven Cancer Institute, Leuven, Belgium., Streich G; Centro Médico Austral, Buenos Aires, Argentina., Montero AJ; University Hospitals Seidman Cancer Center-Case Western Reserve University, Cleveland, OH., Forget F; Centre Hospitalier de l'Ardenne-Site de Libramont, Libramont-Chevigny, Belgium., Mouret-Reynier MA; Centre Jean Perrin, Clermont-Ferrand, France., Sohn JH; Yonsei Cancer Center, Yonsei University Health System-Medical Oncology, Seoul, Republic of Korea., Taylor D; Université catholique de Louvain, CHU UCL Namur-Site Sainte-Elisabeth, Namur, Belgium., Harnden KK; Inova Schar Cancer Institute, Fairfax, Virginia., Khong H; Moffit Cancer Center & Research Institute, Tampa, FL., Kocsis J; Bács-Kiskun Megyei Kórház, Kecskemét, Hungary., Dalenc F; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Dillon PM; University of Virginia Cancer Center, Charlottesville, VA., Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN., Waters S; Velindre Cancer Centre, Cardiff, United Kingdom., Deleu I; AZ Nikolaas, Sint-Niklaas, Belgium., García Sáenz JA; Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., Bria E; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy., Cazzaniga M; Ospedale San Gerardo-ASST Monza, Monza, Italy., Lu J; University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA., Aftimos P; Institut Jules Bordet - Université Libre de Bruxelles, Brussels, Belgium., Cortés J; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain.; Scientific Department, Medica Scientia Innovation Research, Valencia, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., Liu S; Cytel, Waltham, MA., Tonini G; Menarini Group, Florence, Italy., Laurent D; Berlin Chemie AG/Menarini Group, Berlin, Germany., Habboubi N; Stemline Therapeutics/Menarini Group, New York, NY., Conlan MG; Radius Health, Inc, Boston, MA., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Oct 01; Vol. 40 (28), pp. 3246-3256. Date of Electronic Publication: 2022 May 18.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclin-Dependent Kinase 4 ; Estrogen Antagonists/therapeutic use ; Female ; Humans ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Tetrahydronaphthalenes